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Transcription of Epstein-Barr virus (EBV) genes in epithelial tissue, one of the two principal cell types
infected by EBV, is not well characterized. EBV transcription in a nasopharyngeal carcinoma established in
nude mice, C15, has been analyzed by using strand-specific RNA probes and sequence analysis of a C15 cDNA
library. In C15, two equally abundant mRNAs of 3.7 and 2.8 kilobases (kb) are encoded by the sequences that
encode latent membrane protein (LMP). Hybridization with probes specific for the 3' end of the LMP mRNA
to Northern (RNA) blots and sequence analysis of cDNAs representing the messages indicated that the 3.7- and
2.8-kb mRNAs are 3' coterminal. Sequence analysis of additional cDNAs revealed an mRNA that is spliced
identically to the LMP mRNA but is initiated 5' to the promoter for LMP. A probe representing the sequences
contained within the cDNA which are 5' to the LMP promoter identffied the 3.7-kb mRNA in C15 and a
low-abundance 3.7-kb mRNA in B95-8 RNA. These data indicate that transcription of the LMP-encoding
sequences is complex and that LMP can be expressed from an additional RNA in both nasopharyngeal
carcinoma and lymphoid cells. Hybridization with BamHI-A identified a predominant 4.8-kb mRNA and two
less abundant larger-molecular-weight mRNAs transcribed in C15. These mRNAs are consistently expressed in
all passages in nude mice of the C15 tumor. Hybridization with strand-specific probes and sequence analysis
of three cDNAs revealed that these mRNAs are transcribed from left to right. Sequence analysis of cDNAs
representing the 3' end of the mRNAs identified an open reading frame that could potentially encode a protein
of 174 amino acids. In situ hybridization of a 35S-labeled RNA probe homologous to the BamHI-A cDNA to
tissue sections revealed that the BamHI-A mRNA is not focally expressed and is transcribed in all cells within
the C15 tumor. Linear forms of EBV DNA were not detected in any of the C15 tumors, and replicative viral
antigens have not been detected. These data suggest that the C15 tumor represents a latently infected tumor and
that the transcription from BamHI-A, which is expressed in all cells, is not associated with virus replication.
Epstein-Barr virus (EBV), like other herpesviruses, exhib-
its a dual cellular tropism, infecting B lymphocytes and
certain epithelial cells in vivo (4, 30). The ability of the virus
to infect these cell types is thought to be a contributing factor
in the occurrence of two human malignancies, African
Burkitt's lymphoma and nasopharyngeal carcinoma (NPC)
(7, 8, 23).
In vitro, the infection of B lymphocytes with EBV induces
continuous proliferation and establishment of B-cell lines
(20, 21). EBV gene expression has been primarily studied in
these lymphoid cell lines. These studies have revealed that
viral transcription is complex, with multiple intricately and
differentially spliced RNAs (3, 27, 31). Transcripts encoding
each of the six EBV nuclear antigens in B-lymphoid cell lines
all appear to be initiated either within or immediately 5' to
the large internal repeat sequence IR1, whereas the latent
membrane protein (LMP) mRNA is transcribed in the oppo-
site direction from the Dhet fragment at the far right end of
the genome (9, 26, 27).
In comparison, relatively few details are known concern-
ing expression in epithelial cells. It has been difficult to
identify the viral genes expressed in EBV-infected epithelial
cells because cell lines cannot be established from NPC
tumors, nor can epithelial cell lines be generated by infection
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in vitro (24, 30). In addition, NPC tissue does not readily
transplant into nude mice (5). However, analyses of RNA
obtained from NPC tissue taken at biopsy indicated that in
some tumors the same sequences are transcribed as are
found in latently infected lymphocytes (24). In other tumors,
transcription was detected only from the terminal fragment,
DIJhet, or the large internally repeated sequence, IRL. Two
NPC that had been passaged extensively in nude mice
showed transcription from most of the genome, in agreement
with the detection of virus in some of the NPC when
passaged in nude mice, indicative of complete viral replica-
tion in a small proportion of the tumor cells in some nude
mouse-propagated NPC (24).
Another NPC tumor, C15, which has been successfully
heterotransplanted into nude mice, is of particular interest
because protein analyses indicated a restricted pattern of
viral antigen expression similar to that seen in NPC biopsy
specimens (5, 35). EBV transcription has been analyzed in
C15 to identify the viral mRNAs expressed in malignant
epithelial tissues and to characterize transcription from the
DIJhet fragment.
The study presented here revealed that in contrast to
previously analyzed nude mouse passaged NPC, gene
expression in C15 is largely confined to regions coding for
latent gene functions (24, 32). Analysis of the EBV DNA
structure revealed the presence of episomal DNA without
the detection of the linear, virion form of EBV DNA.
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Transcription has not been detected from sequences that
encode immediate-early or early replicative mRNAs, sug-
gesting that EBV expression in this tumor is indeed re-
stricted to latent genes.
In the C15 tumor, two distinct mRNAs, 3.7 and 2.8
kilobases (kb), are transcribed from the sequences that
encode LMP within the EcoRI DIJhet fragment. Sequence
analysis of the C15 LMP cDNAs revealed that the 3.7-kb
mRNA is spliced identically to LMP mRNA but initiates 5'
to the established promoter for LMP. A related mRNA was
also detected in B95-8 cells. These data indicate that LMP
can be encoded by another mRNA which must utilize a
distinct promoter.
The C15 cDNA library also contained cDNAs homologous
to the BamHI A fragment. Hybridization with strand-spe-
cific probes revealed rightward transcription from BamHI-A
in all passages of the C15 tumor. Sequence analysis of the
BamHI-A cDNAs revealed an open reading frame (ORF) at
the 3' end of the mRNAs which could encode a protein of 18
to 20 kilodaltons.
Hybridization in situ detected the BamHI-A and LMP
transcripts in all cells within the C15 tumor. These data
indicate that the BamHI-A transcript does not represent a
replicative transcript which is sporadically expressed in a
few abortively infected cells in the C15 tumor. The consis-
tent detection of transcription from BamHI-A in all cells
within the C15 tumor suggests that in NPC or perhaps in
epithelial cells these sequences encode a function associated
with latent infection.
MATERIALS AND METHODS
Cell cultures and tumor material. The lymphoblastoid
B-cell lines B95-8 (20), Raji (15), Louckes, and CB4 were
grown at 37°C in RPMI 1640 medium with 10% fetal calf
serum and antibiotics. The NPC tumor, C15, is an undiffer-
entiated, nonkeratinizing NPC that has been serially propa-
gated in nude mice (5).
RNA preparation and nucleic acid blotting. Total cellular
RNA was obtained from the cell lines by suspending the
pelleted cells in 4 M guanidine thiocyanate (6). RNA and
DNA were separated by centrifugation through a cesium
chloride step gradient. The DNA fraction was dialyzed to
remove the cesium chloride and guanidine thiocyanate,
treated with proteinase K, and extracted with phenol and
chloroform (29). To obtain RNA from frozen specimens, the
specimens were pulverized in a microdismembrator (Braun
Instruments, Fisher Scientific, Lexington, Mass.) and dis-
solved in 4 M guanidine thiocyanate for CsCl step-gradient
separation (24). poly (A)' RNA was separated from the total
RNA by oligo(dT)-cellulose chromatography (1). The molec-
ular weights of individual mRNAs were determined by
Northern (RNA) blot hybridization after electrophoresis
through a 0.8% agarose-formaldehyde gel and transfer onto
nitrocellulose paper (1, 18).
Preparation of radiolabeled probes and hybridization. Ri-
boprobes were prepared under the following conditions: 1 ,ug
of linearized template in a 50-,ul reaction consisting of 40 mM
Tris hydrochloride (pH 7.5), 6 mM MgCl2, 2 mM spermidine,
100 ,ug of bovine serum albumin per ml, 10 mM dithiothrei-
tol, 0.5 mM unlabeled nucleotides, and 120 ,uCi of [32P]UTP
(19). The 6.8-kb EcoRI-BamHI portion of BamHI-A was
purified by electroelution and was labeled with 32P by nick
translation (25). Hybridization solution consisted of 5 x SSC
(SSC is 0.1 M NaCl plus 0.015 M sodium citrate), ix
Denhardt solution, 0.2% sodium dodecyl sulfate, 100 ,ug of
calf thymus DNA per ml, and 50 mM piperazine-N,N'-bis(2-
ethanesulfonic acid) (PIPES; pH 6.4) in 50% formamide.
Radiolabeled RNA probes were hybridized at 52°C.
cDNA synthesis. A cDNA library was prepared from
poly(A)+ C15 RNA by the method of Gubler and Hoffman
(11). Reagents for this synthesis were obtained in kit form
from Amersham Corp. The double-stranded cDNA was
treated with EcoRI methylase before ligation to EcoRI
linkers, digested with EcoRI, and size fractionated over a
Sepharose CL-4B column. The cDNA was cloned into
EcoRI-digested Agtll, pretreated with calf intestinal alkaline
phosphatase, and plated onto the Escherichia coli Y1090
(36). A second cDNA library was prepared by the same
method, with the modification of using as a primer a syn-
thetic oligomer from bases 168542 to 168562. The cDNAs
were cloned into XgtlO and plated on E. coli C600 hfl.
Screening of the cDNA library. Approximately 3 X 106
bacteriophage Agtll recombinants were plated onto a lawn
of E. coli Y1090 on 150-mm petri dishes, and the phage were
allowed to grow for approximately 8 h. Plaques were trans-
ferred to nitrocellulose filters and hybridized overnight to
EBV virion DNA labeled with 32P by nick translation (25).
The filters were washed for 2.5 h at 68°C in 0.1 x SSC-2%
sodium dodecyl sulfate-1% sodium pyrophosphate. Positive
plaques were picked and purified. Inserts were excised and
subcloned into pGem2 vector for amplification and sequenc-
ing. The AgtlO library was screened with a 1.9-kb XhoI
riboprobe (Fig. 1).
cDNA sequencing. Sequencing of cDNAs was accom-
plished by the GemSeq/RT system (Promega Corp., Madi-
son, Wis.). The cDNAs were ligated into the pGem2 vector,
and an RNA template of the cDNA insert was synthesized in
vitro by using the SP6 or T7 promoters and annealed to
primer complementary to the T7 promoter or vice versa. The
sequencing reaction was accomplished by the dideoxy-chain
termination method of Sanger et al. (28), using reverse
transcriptase in the presence of [35S]dATP. SP6 or T7
promoter primers were used to initiate reverse transcription.
Hybridization conditions in situ. Frozen pieces of the C15
tumor were fixed in 4% paraformaldehyde-0.1% deoxycho-
late-0.1% Triton X-100 in phosphate-buffered saline. The
NPC tissue was divided in pieces and hybridized at 50°C in
50% formamide-600 mM sodium chloride-1 mM EDTA-10
mM dithiothreitol-10% sodium dodecyl sulfate-1 x Den-
hardt solution-10% polyethylene glycol 8000-E. coli tRNA
(0.25 mg/ml)-10 mM Tris hydrochloride (pH 7.5) to antisense
and sense RNA probes representing LMP and BamHI-A
RNAs. The probes were hydrolyzed in alkali to approxi-
mately 100 to 200 base pairs (bp). After hybridization, the
tissues were treated with RNase A (20 ,ug/ml) in 500 mM
NaCl-iOmM Tris (pH 8.0) at 37°C for 30 min. The tissue was
washed, dehydrated, fixed, and sectioned. Slides were
coated with Kodak NTB2 emulsion and exposed for 1 to 3
weeks.
RESULTS
The state of viral infection in C15. Earlier studies of EBV
expression in NPC cultivated in nude mice indicated that
viral expression was not tightly restricted and that virus
replication or abortive infection occurred in some cells (24).
To determine whether foci of cells in the C15 tumor were
permissive for viral replication and produced linear forms of
DNA, the structure of the terminal fragments was analyzed
in each passage of C15 in nude mice.
EBV virion DNA has multiple copies of 500-bp direct
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FIG. 1. Diagram of the coding region for LMP. The top line shows a partial restriction map, with cut sites forBamHI (B), HinclI (H), XhoI
(X), BglII (Bg), and MluI (M) indicated. The second line is a schematic of the mRNA coding for LMP, indicating known promoters. The
transcription start site and splice donor and acceptor sites are numbered according to genomic base pair coordinates from the B95-8 sequence
(2). Probes made from subfragments of this region for Northern blot analysis are as follows: a, BamHI to XhoI; b, BamHI to HincII; c, XhoI
to XhoI; d, BgllI to MluI; e, MluI to bp 169787. These subfragments were transferred to pGem2 vector for the synthesis of strand-specific
riboprobes.
tandem repeats at each terminus (10). After digestion with
restriction enzymes, the terminal fragments are heteroge-
neous in size, varying by increments of 500 bp, and form a
ladder on gels or Southern blots. The linear termini are
joined intracellularly to form covalently closed episomal
DNA (16). The fused terminal fragments can be distin-
guished from the linear forms by their larger size and will
hybridize to probes from either end of the genome. In cell
lines that produce virus, both fused termini and ladder arrays
of smaller fragments are detected (22).
A restriction enzyme map of the BamHI portion of the
Dhet fragment, including two terminal repeats and the struc-
ture of the LMP gene, is shown in Fig. 1; the kilobase
coordinates with respect to the B95-8 genome are designated
(2). Hybridization with a 32P-labeled 1.9-kb XhoI fragment
(Fig. 1, probe c), representing unique DNA adjacent to the
terminal repeats, to a Southern blot prepared with BamHI-
digested DNA from two different passages of C15 and DNA






fragment of 8.0 kb in C15 and a 23-kb fragment in Raji DNA
(Fig. 2A). The fused terminal BamHI fragment in Raji DNA
is exceptionally large because of the loss of the rightmost
BamHI site characteristic of most EBV strains, which is
retained in C15 DNA. Linear forms of the viral DNA were
not detected in any of the nude mouse passages of the C15
tumor. These data suggest that there were no foci of lytically
infected cells in any of the passages of the C15 tumor.
Transcription from the sequences that encode LMP. Earlier
studies ofEBV expression in NPC biopsy specimens or NPC
passaged in nude mice detected abundant transcription from
the EcoRI Dhet fragment (24). To identify the specific
mRNAs encoded by EcoRI DIJhet, the 1.9-kb XhoI frag-
ment within the LMP-coding sequences (Fig. 1, probe c) was
used to compare transcription in C15 with that in lymphoid
cell lines. The XhoI 1.9-kb probe identified a highly abundant
2.8-kb transcript in poly(A)+ RNA from B95-8 cells and a
2.8-kb mRNA in the CB4 cell line, which was established by
infection of neonatal lymphocytes with B95-8. In C15, two
C











FIG. 2. (A) Identification of the EBV terminal fragments. Shown is hybridization of a 32P-labeled XhoI 1.9-kb fragment (Fig. 1, probe c)
to DNA digested with BamHI from two separate passages of C15 and the lymphoid cell line Raji. Sizes of the fragments are indicated on the
left. (B) Identification ofmRNAs homologous to LMP-encoding sequences. Shown is hybridization to a Northern blot prepared with poly(A)+
RNA from C15 and the EBV-infected lymphoid cell lines CB4 and B95-8 to a strand-specific riboprobe complementary to LMP (Fig. 1, probe
c). Arrowheads indicate locations of the 5.0- and 2.0-kb rRNAs. (C) Relative abundance of the LMP mRNA in C15, CB4, and B95-8 cells.
A Northern blot prepared with poly(A)+ RNA from C15, CB4, B95-8, and the EBV-negative lymphoid cell line Louckes (Lks) was hybridized
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FIG. 3. Sequence of LMP-specific cDNAs in C15. Symbols: M, sequenced region; - -, inferred sequence. The primer used for cDNA
synthesis of C101, C102, C103, and C104 from bp 168542 through 168562 is indicated. C104 contained the primer sequence but did not contain
the intervening sequence to base 168742.
mRNAs of approximately equal abundance of 2.8 and 3.7 kb
were detected (Fig. 2B).
In B95-8, the LMP mRNA is initiated from the EDLi
promoter at bp 169512 (9, 14). A related abundant 2.8-kb
mRNA is transcribed during replication from the EDLla
promoter (Fig. 1) (14). To determine the relative abundance
of the 2.8- and 3.7-kb mRNAs in C15 in comparison with the
LMP mRNA in B95-8 and CB4, a Northern blot was
hybridized to a probe that spans the sequences from the
BglII site at bp 169033 to the MluI site at bp 169566 (Fig. 1,
probe d). This probe is relatively specific for the LMP RNA
initiated from the EDL1 promoter, since only 135 of the 533
bp are included in the replicative mRNA transcribed from
the EDLla promoter. A small amount of probe for actin
mRNA was included in the hybridization to determine the
relative levels ofRNA per lane. Because the LMP mRNA is
abundantly transcribed in B95-8, to permit alignment with
the C15 mRNA, the blot was prepared with approximately
one-fourth as much B95-8 RNA. The actin probe identified
the 2.2-kb actin mRNA at equivalent levels in C15 and in
CB4 and at an expected lower level in B95-8. The 5'-end
LMP probe identified the 3.7- and 2.8-kb mRNAs at equiv-
alent levels in C15, an equally abundant 2.8-kb mRNA in
CB4, and an abundant 2.8-kb mRNA in the B95-8 lane,
which contained much less total RNA (Fig. 2C). In the
EBV-negative lymphoid line, Louckes, only the 2.2-kb actin
mRNA was identified. These data revealed that the two
mRNAs in C15 contained sequences specific for the 5' end of
LMP and were transcribed at approximately the same level
as the LMP mRNA in the CB4 cell line.
To further characterize the 2.8- and 3.7-kb mRNAs,
probes were constructed which extended from the BamHI
site at bp 166614 to the XhoI site at bp 167487 (Fig. 1, probe
a) and to the HincII site at bp 167052 (Fig. 1, probe b). In
B95-8, the LMP mRNA utilizes the polyadenylation signal at
bp 166950 and terminates approximately at bp 166930. These
probes overlap the LMP mRNA coding sequence at the 3'
end by approximately 550 and 120 bp, respectively, and
therefore should hybridize more strongly to the 3.7-kb
message if it extends past the LMP termination signal. The
probes identified the 3.7- and 2.8-kb messages in C15 wit4
approximately equal intensity (data not shown), suggesting
that both RNAs terminate at the polyadenylation signal at bp
166950.
Analysis of C15 cDNAs. To analyze EBV expression in
NPC in greater detail, a cDNA library was constructed in
Xgtll from polyadenylated RNA after priming first-strand
synthesis with oligo(dT). Alternative polyadenylation and
splicing are key elements in the regulation of EBV expres-
sion; therefore, priming cDNA synthesis with oligo(dT)
should produce a cDNA library which is representative of
the processed mRNA population (20). EBV-positive clones
that were homologous to the coding region of LMP were
identified. Restriction enzyme analysis of the longest cDNA,
C31, indicated that this 1.8-kb cDNA was colinear with the
3' end of LMP (Fig. 3).
The LMP cDNAs were subcloned into the pGem2 vector
(Promega) and were sequenced by the GemSeq method. The
sequence of the left end of the cDNAs (C31, C21h, C22, and
C211) revealed that the cDNAs extended to bp 166951,
apparently utilizing the polyadenylation signal at bp 166950,
the same signal utilized by the LMP transcript in B95-8 and
in IB-4, a cell line established by infection of neonatal
lymphocytes with B95-8 (Fig. 3) (9, 14). The cDNAs retained
multiple restriction sites common to the 3' exon of LMP
(data not shown). The rightward end of C31 and C24 were
also sequenced. These data, together with the size estima-
tion of the cDNAs, indicated they were not spliced. Base
pair polymorphisms were not detected in the sequenced
regions of these five cDNAs.
To further characterize the 2.8- and 3.7-kb transcripts, a
synthetic oligomer, representing bp 168542 to 168562, com-
plementary to the LMP mRNA at a region 3' to the second
splice acceptor site was used as a primer for the synthesis of
second cDNA library that would extend further 5' (Fig. 4).
Four cDNAs were identified. The C101 (0.8 kb), C102 (0.4
kb), C103 (0.9 kb), and C104 (0.3 kb) cDNAs were subcloned
into pGem2 and sequenced. The sequenced regions are
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FIG. 4. Identification of the 3.7-kb mRNA. Duplicate blots were
prepared with poly(A)+ RNA from C15, CB4, and B95-8 cells.
Lanes A were hybridized to 165 x 106 cpm of a strand-specific
riboprobe prepared from the C101 cDNA representing sequences 5'
to the start of the LMP mRNA (Fig. 1, probe e); lanes B were
hybridized to 175 x 106 cpm of the probe representing the 5' end of
the LMP mRNA and to 2 x 106 cpm of actin probe. The individual
lanes for C15, CB4, and B95-8 were aligned by using the internal
rRNAs (arrowheads).
presented in Fig. 3B. One of these cDNAs, C103, revealed
two splices that are identical to the splices of the latent form
of LMP (14). The 5' end of this cDNA extended to bp
169714, which is 200 bp 5' to the transcription initiation site
for LMP in IB-4 and B95-8. This indicated that a transcript
that could encode LMP can be initiated from a different
promoter.
Both C101 and C104 contain sequences that represent
intron sequences in B95-8 and in the C103 cDNA. The size of
the C101 cDNA and the presence of characteristic restriction
enzyme cut sites suggested that there are no splices in the
unsequenced region of the C101 cDNA. It is likely that the
C101 and C104 cDNAs represent unspliced precursor
RNAs, since these cDNAs were synthesized by using a
specific oligonucleotide. A cDNA library synthesized from
C15, which was primed with random oligonucleotides, also
contained spliced and unspliced cDNAs (13).
To identify the mRNAs represented by these cDNAs, the
5' end of the C101 cDNA was subcloned from the MluI site
at bp 169566 to the end of the cDNA at bp 169787. This probe
only contains sequences which are 5' to the published LMP
mRNA start site and which were part of the unspliced C101
cDNA and the spliced C103 cDNAs (Fig. 1, probe e).
Duplicate Northern blots were prepared with RNA from
C15, CB4, and B95-8. One panel was hybridized to the
cDNA 5' end subclone (Fig. 1, probe e). The second panel
was hybridized to the 5' end LMP probe (Fig. 1, probe d) and
to a small amount of actin probe. After hybridization, the
individual lanes were aligned, using the rRNAs as internal
size markers. The 5' end LMP probe identified both the 2.8-
and 3.7-kb mRNAs in C15, which were expressed at equal
levels (Fig. 4A, lane B). The probe also identified a discrete
2.8-kb mRNA in CB4 and an abundant 2.8-kb mRNA in
B95-8 which trailed into the 3.7-kb size range. The 5' end
cDNA probe identified the 3.7-kb mRNA in C15 and a 3.7-kb
mRNA in B95-8 but did not identify the 2.8-kb mRNA in
C15, B95-8, or CB4 (Fig. 4, lanes A). These data indicate
that in C15, the 3.7-kb mRNA but not the 2.8-kb mRNA
contains sequences 5' to the LMP promoter. A related
3.7-kb mRNA is transcribed in B95-8 at much lower levels
than the 2.8-kb LMP mRNA. The presence of the 3.7-kb
mRNA in B95-8 RNA is obscured by the abundant 2.8-kb
LMP mRNA; therefore, it can only be detected by a probe
that does not hybridize to the 2.8-kb LMP mRNA. These
hybridizations and the sequence data suggest that the C103
cDNA, which would encode LMP, represents the 3.7-kb
mRNA.
Polymorphisms of LMP sequence. A total of seven base
pair polymorphisms were observed in the sequence of the
C103 cDNA as compared with B95-8 (Fig. 5) (2). One of
these polymorphisms, a conversion of a T to an A, is present
in the untranslated region 5' to the translation start site of
LMP at bp 169474. The other six are present in the coding
region for LMP, and all theoretically cause changes in the
amino acid sequence when compared with the EBV strain
B95-8 (Fig. 5). The amino acid conversions were all conserv-
ative and would alter neither the net charge nor the probable
conformation of the protein. Five of the six changes are
located in the amino-terminal transmembrane region of the
protein. The other substitution was detected in the C102
cDNA and occurred in the negatively charged carboxy
terminus, resulting in conversion of a serine to a threonine.
Transcription from the BamHI-A region. The C15 cDNA
library primed with oligo(dT) contained several clones ho-
mologous to BamHI-A. To identify the mRNAs represented
by these cDNAs, a nick-translated probe consisting of the
EcoRI Dhet portion ofBamHI-A was hybridized to a North-
ern blot of C15 and B95-8 RNA (Fig. 6A). This probe
identified a 4.8-kb mRNA in the C15 sample and a 4.2-kb
message in both uninduced and 12-O-tetra decanoylphorbol-
13-acetate-induced B95-8 samples. Related mRNAs were
not detected in either Raji or CB4, although other early
mRNAs expressed from other regions of the viral genome
could be detected in these cell lines.
One of the cDNAs homologous to BamHI-A, C25a, was
estimated to be 1.3 kb long and contained a single EcoRI
site. The C25a cDNA and the EcoRI subfragments were
transferred to the pGem2 vector for sequence analysis and to
generate strand-specific riboprobes for Northern blot analy-
sis. A strand-specific riboprobe synthesized from the 1.3-kb
C25a cDNA was hybridized to a Northern blot that con-
tained lanes of C15 and CB4 duplicate to those shown in Fig.
2C. The C25a cDNA probe identified in C15 RNA an
abundant 4.8-kb mRNA transcribed rightward and two
larger mRNAs of 6.4 and 7.6 kb (Fig. 6B). This finding was
surprising since the cDNAs were within a major leftward
ORF, BALF3, and a rightward ORF was not described (2).
Although both the LMP mRNA and actin mRNA were
readily detected in the duplicate blot of CB4 RNA (Fig. 2C),
transcription from BamHI-A was not detected in CB4 RNA.
Sequence analysis of three of the BamHI-A cDNAs re-
vealed that all three terminated at an AATAAA polyadeny-
lation signal at bp 160986 (Fig. 6C). The longest of the
cDNAs, C25a, terminated at the left end at bp 159541. The
sequence of this cDNA revealed a single splice which
eliminated an intron of 171 bp. A search for rightward ORFs
in C25a identified a methionine codon 752 bases downstream
of the 5' end of the cDNA at bp 160293, within an uninter-
rupted reading frame extending nearly the entire length of
the cDNA. An identical ORF is present in the B95-8 se-
quence and extends from bp 159579 through 160991 (2).
Although a stop codon is not present in the cDNA, a TAA
stop codon is 6 bp 3' to the end of the cDNA and is
presumably present in the analogous polyadenylated parent
molecule. This ORF would produce a peptide of 18 to 20
J. VIROL.


























































kilodaltons. A C15 cDNA library prepared by using random
hexamers as primer for cDNA synthesis has been previously
described. This library contained multiple spliced and un-
spliced cDNAs homologous to BamHI-A; however, the
cDNAs did not encompass the 3' end of the mRNAs and did
not contain this ORF.
Hybridization in situ. To identify the functions expressed
in latent lymphoid infection, it was important to determine
that the cell lines did not express RNAs associated with
virus replication and to demonstrate that the function is
expressed in every latently infected cell. Although transcrip-
tion from the BamHI Z, H, and M fragments, which encode
functions involved in replication, was not detected (data not
shown), it is possible that replicative mRNAs could be
abundantly expressed in a few abortively infected cells the
majority of which are latently infected. To investigate the
extent of expression of the BamHI-A gene in comparison
with LMP, pieces of the C15 tumor were hybridized in situ to
35S-labeled RNA probes synthesized from the BamHI cDNA
and the XhoI 1.9-kb fragment in both sense and antisense
orientations. Hybridization with the single-stranded RNA
probe antisense to the BamHI-A mRNA revealed that the
mRNA was expressed in all cells within the C15 tumor (Fig.
7A). Hybridization was specific to the tumor cells and was
not detected in the normal mouse epithelium at the bottom
left of the tissue section. Hybridization with an RNA probe
antisense to the LMP mRNA (shown at higher magnification
in Fig. 7B) detected LMP transcription specifically in all of
the tumor cells. Hybridization with the sense probes for both
BamHI-A and LMP was negative, indicating that the oppo-
site strands were not transcribed and that hybridization was
specific for the EBV RNAs and was not detecting EBV DNA
(Fig. 7C and D).
DISCUSSION
This study reveals several differences in virus expression
in an NPC, C15, in comparison with the prototype lymphoid
strain, B95-8. In the C15 tumor, two mRNAs are transcribed
from the sequences that encode LMP. Interestingly, se-
quence analysis of the C15 LMP cDNAs suggests that
another promoter can be utilized for LMP expression. The 5'
end of the C103 cDNA, which is spliced identically to the
B95-8 LMP mRNA and could encode LMP, is at bp 169714,
200 bp 5' to the LMP promoter identified in B95-8-trans-
formed lymphocytes. A probe representing these sequences
identified the 3.7-kb mRNA in C15 and in B95-8. Since the 5'
end of the C103 cDNA is only 200 bp away from the start of
the terminal repeats (TR), the 3.7-kb mRNA may be a
transcript that originates at the left end of the EBV genome
and is transcribed leftward across the TR from the episomal
DNA or may initiate within the TR. Two other mRNAs that
originate in BamHI-A and transverse the TR rightward have
been described in B95-8 (17). The detection of the 3.7-kb
mRNA in B95-8 and C15 suggests that a putative promoter
for LMP at the left end of the genome may be utilized in both
lymphoid and epithelial cells. Two potential promoters have
been described for expression of the EBNAs (3, 27). The
data presented here suggest that the regulation of LMP may
be equally complex and that different promoters may be used
FIG. 5. Sequence of LMP in C15, showing a comparison of the
C103 cDNA sequence data with the sequence ofLMP in B95-8 cells.
Differences in nucleotides and amino acids are in boldface. ---,
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FIG. 6. Identification of mRNAs encoded by BamHI-A. (A) The
C15 CB4 6.7-kb EcoRI-BamHI subfragment of BamHI-A was labeled with32p by nick translation and hybridized to a Northern blot prepared
with poly(A)+ RNA from C15, Raji, CB4, and uninduced (B95)
and 12-O-tetradecanoylphorbol-13-acetate-induced (B95-Ind) B95-8
cells. Positions of rRNAs are indicated with arrowheads. Sizes of
identified mRNAs are indicated. (B) Identification of the mRNAs
represented by the C15 cDNAs homologous to BamHI-A. A strand-U specific riboprobe synthesized from right to left was prepared from
the C25a cDNA, representing bases 160986 to 159541. The probe
was hybridized to a Northern blot containing poly(A)+ RNA from
C15 and CB4 prepared in duplicate with that shown in Fig. 2C.
rRNAs are indicated with arrowheads. (C) Structure of the BamHI
A cDNAs. The schematic at the top is a partial restriction map of
BamHI-A from bp 158747 to 161747. Symbols: _, sequenced
















in different situations. The 3.7-kb mRNA but not the 2.8-kb
mRNA has also been identified in mRNA from an NPC
biopsy; therefore, it is possible that the promoter for this
mRNA is more frequently utilized in NPC or perhaps in
epithelial cells (22).
Sequence analysis of the C15 LMP cDNAs reveals several
changes in comparison with the LMP sequence in B95-8
cells. Seven base pair changes were detected in the sequence
of 800 bp of the 5' end of the LMP cDNA. Of these, six result
in conservative amino acid changes that would not alter the
net charge or folding pattern of the protein. This may
indicate structural and functional constraints on variation in
LMP. Sequence analysis of the LMP-encoding sequence in
the Raji EBV strain revealed 30 base pair substitutions in
1,300 nucleotides, resulting in 21 amino acid substitutions
(12). Although the LMP-encoding sequence in C15 is con-
siderably less divergent than in the Raji strain, there may be
selection favoring antigenic variation in LMP while conserv-
ing important structural components.
LMP is apparently an important component in EBV-
induced transformation in that it has profound effects on the
phenotype of lymphoid cells and can transform Rat-1 cells in
vitro, conferring the ability to grow in nude mice (33, 34). As
it is a rare NPC that can be established in nude mice, the
successful transplantation of the C15 tumor may reflect the
continued expression of LMP, which may not be expressed
in all tumors in vivo (5). Analysis ofEBV proteins expressed
in NPC biopsy samples detected LMP in approximately half
of the tumors and detected strong expression of the 60-
kilodalton full-length form of LMP in C15 on immunoblots
probing with the CS1-4 pool of monoclonal antibodies.
However, another anti-LMP monoclonal antibody, S12, did
not react with C15 LMP (36). It is possible that divergence in
the LMP expressed in NPC biopsy specimens may have
prevented recognition by the monoclonal antibodies.
The detection of transcription from the BamHI A fragment
is intriguing in that BamHI-A is not transcribed in latently
infected lymphocytes. The lack of detectable linear DNA or
expression of early functions in C1S indicates that the
BamHI-A transcripts are not associated with replication
(36). A recent study of EBV transcription in C15 also
identified abundant cDNAs from the BamHI A and adjacent
BamHI I fragments in a library synthesized by using random
oligonucleotides as primer (18). This library represented
total RNA and contained both spliced and unspliced cDNAs.
The absence of a major ORF within the previously described
cDNAs prompted the suggestion that the RNAs may be
negative regulators for expression of replication functions
encoded by the opposite strand. However, the cDNAs
analyzed here were synthesized by priming with oligo(dT)
and encompassed the 3' end of the mRNAs. The sequence of
these cDNAs revealed an ORF with an internal methionine
codon that could potentially encode an 18- to 20-kilodalton
protein. The consistent expression of rightward transcription
from this ORF in all of the C1S tumor cells suggests that this
ORF encodes an essential function in epithelial cells.
The regulation of herpesvirus expression is complex and
involves both cellular and virus-encoded transcription fac-
tors. Therefore, it is likely that epithelial- or lymphoid-
specific cellular transcription factors would influence the
expression of viral genes. The expression of distinct viral
genes could, in turn, alter the growth regulation of epithelial
or lymphoid cells. It is possible that the 3.7- and 4.8-kb
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FIG. 7. Detection of the BamHI-A RNA and LMP RNA in situ. (A) A 35S-labeled RNA probe synthesized to the BamHI-A cDNA,
homologous to the mRNA, was hybridized to a piece of C15 tissue, exposed to emulsion for 1 week, and photographed. Magnification, x400.
(B) A 35S-labeled RNA probe homologous to the LMP mRNA was hybridized to C15 tissue, exposed to emulsion for 1 week, and
photographed. Magnification, x1,000. (C) A 35S-labeled RNA probe synthesized in the sense orientation to the BamHI A cDNA was
hybridized to C15 tissue, exposed to emulsion for 1 week, and photographed. Magnification, x400. (D) A 35S-labeled RNA probe synthesized
in the sense orientation to the LMP mRNA was hybridized to C15 tissue, exposed to emulsion for 1 week, and photographed. Magnification,
x 1,000.
consistent expression of the BamHI-A transcript in all of the
EBV-infected epithelial cells suggests that the mRNA en-
codes a critical function that is involved in maintenance of
latency in epithelial cells or affects cellular proliferation.
ACKNOWLEDGMENTS
We are grateful for the excellent assistance of Kathryn Flynn and
Stephanie Oberhaus.
This work was supported by Public Health Service grant CA
19014 from the National Cancer Institute.
LITERATURE CITED
1. Aviv, H., and P. Leder. 1972. Purification of biologically active
globin messenger RNA by chromatography on oligothymidylic
acid-cellulose. Proc. Natl. Acad. Sci. USA 69:1408-1412.
2. Baer, R., A. Bankier, M. Biggin, P. Deinenger, P. Farrell, T.
Gibson, G. Hatfull, G. Hudson, S. Satchwell, C. Sequin, P.
Tuffnell, and B. Barrell. 1984. DNA sequence and expression of
the B95-8 Epstein-Barr virus. Nature (London) 310:207-211.
3. Bodescot, M., M. Perricaudet, and P. J. Farrell. 1987. A
promoter for the highly spliced EBNA family of RNAs of
Epstein-Barr virus. J. Virol. 61:3424-3430.
4. Brown, N. A., C. Liu, C. R. Garcia, Y. F. Wang, A. Griffith,
VOL. 64, 1990
?i.



















r jeS i ¢
J i E
ow.,rr: ., } / t io.











4956 GILLIGAN ET AL.
R. S. Sparkes, and K. L. Calame. 1986. Clonal origins of
lymphoproliferative disease induced by Epstein-Barr virus. J.
Virol. 58:975-978.
5. Busson, P., G. Ganem, P. Flores, F. Mugneret, B. Clausse, B.
Caillou, K. Braham, H. Wakasugi, M. Lipinski, and T. Tursz.
1988. Establishment and characterization of three transplant-
able EBV-containing nasopharyngeal carcinomas. Int. J. Can-
cer 42:599-606.
6. Chirgwin, J. M., A. E. Przbyla, R. J. MacDonald, and W. J.
Rutter. 1979. Isolation of biologically active ribonucleic acid
from sources enriched in ribonuclease. Biochemistry 18:5294-
5299.
7. Desgranges, C., H. Wolf, G. de The', K. Shanmugaratnam, R.
Ellouz, N. Cammoun, G. Klein, and H. zur Hausen. 1975.
Nasopharyngeal carcinoma X. Presence of Epstein-Barr virus
genomes in epithelial cells of tumors from high and medium risk
areas. Int. J. Cancer 16:7-15.
8. Epstein, M. A., B. G. Achong, and Y. M. Barr. 1964. Virus
particles in cultured lymphoblasts from Burkitt's lymphoma.
Lancet i:702-703.
9. Fennewald, S., V. van Santen, and E. Kieff. 1984. Nucleotide
sequence of an mRNA transcribed in latent growth-transform-
ing virus infection indicates that it may encode a membrane
protein. J. Virol. 51:411-419.
10. Given, D., D. Yee, K. Griem, and E. Kieff. 1979. DNA of
Epstein-Barr virus. V. Direct repeats at the ends of Epstein-
Barr virus DNA. J. Virol. 30:852-862.
11. Gubler, U., and B. Hoffman. 1983. A simple and very efficient
method for generating cDNA libraries. Gene 25:263-269.
12. Hatful, G., A. T. Bankier, B. G. Barrell, and P. J. Farrell. 1988.
Sequence analysis of Raji Epstein-Barr virus DNA. Virology
164:334-340.
13. Hitt, M. M., M. J. Allday, T. Hara, L. Karran, M. D. Jones, P.
Busson, T. Tursz, I. Ernberg, and B. E. Griffin. 1989. EBV gene
expression in an NPC-related tumor. EMBO J. 8:2639-2651.
14. Hudson, G. S., P. J. Farrell, and B. G. Barrell. 1985. Two
related but differentially expressed potential membrane proteins
encoded by the EcoRI Dhet region of Epstein-Barr virus, B95-8.
J. Virol. 53:528-535.
15. King, W., A. Thomas-Powell, N. Raab-Traub, M. Hawke, and E.
Kieff. 1980. Epstein-Barr virus RNA. V. Viral RNA in a
restringently infected growth-transformed cell line. J. Virol.
36:506-518.
16. Kintner, C. R., and B. Sugden. 1979. The structure of the
termini of the DNA of Epstein-Barr virus. Cell 17:661-671.
17. Laux, G., M. Perricaudet, and P. J. Farrell. 1988. A spliced
Epstein-Barr virus gene expressed in immortalized lymphocytes
is created by circularizarion of the linear viral genome. EMBO
J. 7:769-774.
18. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular
cloning: a laboratory manual. Cold Spring Harbor Laboratory,
Cold Spring Harbor, N.Y.
19. Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K.
Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of
biologically active RNA and RNA hybridization probes from
plasmids containing a bacteriophage SP6 promoter. Nucleic
Acids Res. 12:7035-7056.
20. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-
Barr virus by transformed marmoset leukocytes. Proc. Natl.
Acad. Sci. USA 70:190-194.
21. Pope, J., M. Horne, and W. Scott. 1968. Transformation of fetal
human leukocytes in vitro by filtrates of a human leukemic cell
line containing herpes-like virus. Int. J. Cancer 3:857-866.
22. Raab-Traub, N., and K. Flynn. 1986. The structure of the
termini of the Epstein-Barr virus as a marker of clonal cellular
proliferation. Cell 47:883-889.
23. Raab-Traub, N., K. Flynn, G. Pearson, A. Huang, P. Levine, A.
Lanier, and J. Pagano. 1987. The differentiated form of nasopha-
ryngeal carcinoma contains Epstein-Barr virus DNA. Int. J.
Cancer 39:25-29.
24. Raab-Traub, N., R. Hood, C. S. Yang, B. Henry, and J. S.
Pagano. 1983. Epstein-Barr virus transcription in nasopharyn-
geal carcinoma. J. Virol. 48:580-590.
25. Rigby, P. W. J., M. Dieckmann, C. Rhodes, and P. Berg. 1977.
Labeling deoxyribonucleic acid to high specific activity in vitro
by nick translation with DNA polymerase. J. Mol. Biol. 113:
237-251.
26. Rowe, D., P. J. Farrell, and G. Miller. 1987. Novel nuclear
antigens recognized by human sera in lymphocytes latently
infected by Epstein-Barr virus. Virology 156:153-162.
27. Sample, J., M. Hummel, D. Braun, M. Birkenbach, and E. Kieff.
1986. Nucleotide sequences of messenger RNAs encoding Ep-
stein-Barr virus nuclear proteins reveals a probable transcrip-
tional initiate site. Proc. Natl. Acad. Sci. USA 83:6096-5100.
28. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequenc-
ing with chain-terminating inhibitors. Proc. Natl. Acad. Sci.
74:5463-5467.
29. Seeburg, P. H., J. Shine, A. Martial, A. Ullrich, J. D. Baxter,
and H. M. Goodman. 1977. Nucleotide sequence of part of the
gene for human chorionic somatomammotropin: purification of
DNA complementary to predominant mRNA species. Cell
12:157-165.
30. Sixbey, J., E. H. Vesterinen, J. G. Nedrud, N. Raab-Traub, L. A.
Walton, and J. S. Pagano. 1983. EBV replication in human
epithelial cells infected in vitro. Nature (London) 306:480-483.
31. Speck, S., and J. Strominger. 1985. Analysis of a transcript
encoding the latent Epstein-Barr virus nuclear antigen I: a
potentially polycistronic message generated by long range splic-
ing of several exons. Proc. Natl. Acad. Sci. USA 82:568-570.
32. Tugwood, J. D., W.-H. Lau, S.-K. 0, S.-Y. Tsao, W. M. Martin,
W. Shiu, C. Desgranges, P. Jones, and J. Arrand. 1987. Epstein-
Barr virus specific transcription in normal and malignant na-
sopharyngeal biopsies and in lymphocytes from healthy donors
and infectious mononucleosis patients. J. Gen. Virol. 68:1081-
1091.
33. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane
protein expressed in immortalized lymphocytes transforms es-
tablished rodent cells. Cell 43:831-840.
34. Wang, D., D. Liebowitz, and E. Kieff. 1988. The truncated form
of the Epstein-Barr virus latent-infection membrane protein
expressed in virus replication does not transform rodent fibro-
blasts. J. Virol. 62:2337-2346.
35. Young, L., C. Dawson, D. Clark, H. Rupani, P. Busson, T.
Tursz, A. Johnson, and A. Rickinson. 1988. Epstein-Barr virus
gene expression in nasopharyngeal carcinoma. J. Gen. Virol.
69:1051-1065.
36. Young, R. A., and R. Davis. 1983. Efficient isolation of genes by
using antibody probes. Proc. Natl. Acad. Sci. USA 80:1194-
1198.
J. VIROL.
